Three-stage designs for monitoring clinical trials
From MaRDI portal
Publication:4843696
DOI10.1080/03610929408831362zbMath0825.62197MaRDI QIDQ4843696
No author found.
Publication date: 17 August 1995
Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610929408831362
62-XX: Statistics
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Statistical approaches to interim monitoring of medical trials: A review and commentary
- Discrete Sequential Boundaries for Clinical Trials
- Algorithm AS 195: Multivariate Normal Probabilities with Error Bound
- Group sequential tests with censored survival data adjusting for covariates
- The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time
- Stochastically curtailed tests in long–term clinical trials
- An improved method for deriving optimal one-sided group sequential tests
- Optimum Double Sampling Tests of Given Strength I. The Normal Distribution
- Two-Stage Plans Compared with Fixed-Sample-Size and Wald SPRT Plans
- A New Procedure for Group Sequential Analysis in Clinical Trials
- Design and analysis of group sequential tests based on the type I error spending rate function
- Operating Characteristic Curves and Accept-Reject Rules for Two and Three Stage Screening Procedures
- Optimum Character of the Sequential Probability Ratio Test
- A Double Sample Test Procedure